Indoles - A promising scaffold for drug development

European Journal of Pharmaceutical Sciences

Volumn 91, Issue , 2016, Pages 1-10

  Sravanthi, T V ^a   Manju, S L ^a  

^a VIT UNIVERSITY   (India)

Author keywords

2 arylindoles; Bioactive molecules; Design new therapeutics; Heterocycles; Marketed drugs; Natural alkaloids

Indexed keywords

ALKALOID; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANTIPARKINSON AGENT; ANTIVIRUS AGENT; HETEROCYCLIC COMPOUND; HYPOCHOLESTEROLEMIC AGENT; INDOLE DERIVATIVE;

ANTIDIABETIC ACTIVITY; ANTIHISTAMINIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; DRUG ACTIVITY; DRUG DESIGN; DRUG MARKETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL;

ANIMALS; DRUG DESIGN; HUMANS; INDOLES;

EID: 84973106784     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2016.05.025     Document Type: Review

References (66)

1. H. Abdel-Gawad, H.A. Mohamed, K.M. Dawood, and F. Abdel-Rahem Badria Synthesis and antiviral activity of new indole-based heterocycles Chem. Pharm. Bull. 58 11 2010 1529 1531
2. E. Abele, R. Abele, O. Dzenitis, and E. Lukevics Indole and isatin oximes: synthesis, reactions and biological activity Chem. Heterocycl. Compd. 39 1 2003 3 35
3. L. Almagro, F. Fernandez-Perez, and M.A. Pedreno Indole alkaloids from Catharanthus roseus: bioproduction and their effect on human health molecules 20 1 2015 2973 3000
4. J. Alvarez-Builla, J.J. Vaquero, and J. Barluenga Modern Heterocyclic Chemistry: Chapter -5: Five-Membered Heterocycles: Indole and Related Systems 5 2011 Wiley-VCH Verlag GmbH & Co. KGaA Germany 377
5. K.E. Andersson Pharmacology of penile erection Pharmacol. Rev. 53 3 2001 417 450
6. I. Andreadou, A. Tasouli, E. Bofilis, M. Chrysselis, E. Rekka, A. Tsantili-Kakoulidou, E. Iliodromitis, T. Siatra, and D.T. Kremastinos Antioxidant activity of novel indole derivatives and protection of the myocardial damage in rabbits Chem. Pharm. Bull. 50 2 2002 165 168
7. S. Battaglia, E. Boldrini, F.D. Settimo, G. Dondio, C.L. Motta, A.M. Marini, and G. Primofiore Indole amide derivatives: synthesis, structure-activity relationships and molecular modeling studies of a new series of histamine H1-receptor antagonists Eur. J. Med. Chem. 34 2 1999 93 105
8. R. Bellimin, A. Decerprit, and D. Festal New indole derivatives as ACAT inhibitors: synthesis and structure-activity relationships Eur. J. Med. Chem. 31 2 1996 123 132
9. M. Berger, J.A. Gray, and B.L. Roth The expanded biology of serotonin Annu. Rev. Med. 60 1 2009 355 366
10. S. Biswal, U. Sahoo, S. Sethy, H.K.S. Kumar, and M. Banerjee Indole: the molecule of diverse biological activities Asian J. Pharm. Clin. Res. 5 1 2012 1 6
11. J.M. Coelho Filho, and J. Birks Physostigmine for Dementia Due to Alzheimer's Disease 2 2001 John Wiley & Sons Chichester, UK 1
12. N. Dalip Kumar, M. Kumar, B. Noel, and K. Shah A series of 2-arylamino-5-(indolyl)-1,3,4-thiadiazoles as potent cytotoxic agents Eur. J. Med. Chem. 55 1 2012 432 438
13. N. Dalip Kumar, M. Kumar, S. Sundaree, O. Emmanuel Johnson, and K. Shah An expeditious synthesis and anticancer activity of novel 4-(3′-indolyl)oxazoles Eur. J. Med. Chem. 45 3 2010 1244 1249
14. R.J. Deschenes, H. Lin, A.D. Ault, and J.S. Fassler Antifungal properties and target evaluation of three putative bacterial Histidine kinase inhibitors Antimicrob. Agents Chemother. 43 7 1999 1700 1703
15. DHHS panel Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents 2006, May 4
16. D.S. Donawade, A.V. Raghu, and G.S. Gadaginamath Synthesis and antimicrobial activity of new 1-substituted-3-pyrrolyl aminocarbonyl/oxadiazolyl/triazolyl/5-methoxy-2-methylindoles and benz[g]indoles Indian J. Chem. B 45 3 2006 689 696
17. J.L. Falco, M. Pique, M. Gonzalez, I. Buira, E. Mendez, J. Terencio, C. Perez, M. Princep, A. Palomer, and A. Guglietta Synthesis, pharmacology and molecular modelling of N-substituted 2-phenyl-indoles and benzimidazoles as potent GABAA agonists Eur. J. Med. Chem. 41 8 2006 985 990
18. R. Gastpeer, M. Goldbrunner, D. Marko, and E.V. Angerer Methoxysubstituted 3-formyl-2-phenylindoles inhibit tubulin polymerization J. Med. Chem. 41 25 1998 4965 4972
19. R.T. Hendricks, D. Sheramn, B. Strulovici, and C.A. Broka 2-aryl-indolyl maleimides - novel and potent inhibitors of protein kinase C Bioorg. Med. Chem. Lett. 5 1 1995 67 72
20. Y.M.A. Hiari, A.M. Qaisi, M.M. Abadelah, and W. Voelter Synthesis and antibacterial activity of some substituted 3-(aryl)- and 3-(heteroaryl)indoles Monatshefte Fur Chemie 137 2 2006 243 248
21. W. Hu, Z. Guo, X. Yi, C. Guo, F. Chu, and G. Cheng Discovery of 2-phenyl-3-sulfonylphenyl-indole derivatives as a new class of selective COX-2 inhibitors Bioorg. Med. Chem. 11 24 2003 5539 5544
22. M.T. Isaac Review: combining pindolol with an SSRI improves early outcomes in people with depression Evid. Based Ment. Health 7 4 2004 107 130
23. C. Karaaslan, H. Kadri, T. Coban, S. Suzen, and A.D. Westwell Synthesis and antioxidant properties of substituted 2-phenyl-1H-indoles Bioorg. Med. Chem. Lett. 23 9 2013 2671 2674
24. D. Kaufmann, M. Pojarova, S. Vogel, R. Liebl, R. Gastpar, D. Gross, T. Nishino, T. Pfaller, and E. Von Angerer Antimitotic activities of 2-phenylindole-3-carbaldehydes in human breast cancer cells Bioorg. Med. Chem. 15 15 2007 5122 5136
25. S. Kher, K. Lake, I. Sircar, M. Pannala, F. Bakir, J. Zapf, K. Xu, S.H. Zhang, J. Liu, L. Morera, N. Sakurai, R. Jack, and J.F. Cheng 2-aryl-N-acylindole derivatives as liver X receptor (LXR) agonists Bioorg. Med. Chem. 17 16 2007 4442 4446
26. A.J. Kochanowska-Karamyan, and M.T. Hamann Marine indole alkaloids: potential new drug leads for the control of depression and anxiety Chem. Rev. 110 8 2010 4489 4497
27. S.D. Kuduk, R.K. Chang, J.M.C. Wai, C.N. Di Marco, V. Cofre, R.M. Di-Pardo, S.P. Cook, M.J. Cato, A. Jovanovska, M.O. Urban, M. Leitl, R.H. Spencer, S.A. Kane, G.D. Hartman, and M.T. Bilodeau Amidine derived inhibitors of acid-sensing ion channel-3 (ASIC3) Bioorg. Med. Chem.Lett. 19 15 2009 4059 4063
28. D. Kumar, N. Kumar, S. Kumar, T. Singh, and C.P. Singh Synthesis of pharmacologically active 2-phenyl sulpha/substituted indoles Int. J. Eng. Sci. Tech. 2 7 2010 2553 2557
29. S. Kumar, H. Kaur, K.K. Saxena, M. Sharma, P. Vishwakarma, and A. Kumar Synthesis and antiparkinsonian activity of some new adamantyl thiazolidinonyl/azetidinonyl indole derivatives Indian J. chem. B 49 10 2010 1398 1405
30. S. Lakhdar, M. Westermaier, F. Terrier, R. Goumont, T. Boubaker, A.R. Ofial, and H. Mayr Nucleophilic reactivities of indoles J. Org. Chem. 71 24 2006 9088 9095
31. S. Lal, and T.J. Snape 2-arylindoles: a privileged molecular scaffold with potent, broad-ranging pharmacological activity Curr. Med. Chem. 19 28 2012 4828 4837
32. T.C. Leboho, J.P. Michael, W.A.L. Van Otterlo, S.F. Van Vuuren, and C.B. De Koning The synthesis of 2- and 3-aryl indoles and 1,3,4,5- tetrahydropyrano[4, 3-b] indoles and their antibacterial and antifungal activity Bioorg. Med. Chem. Lett. 19 17 2009 4948 4951
33. D. Lednicer The organic chemistry of drug synthesis-A 7 2007 John Wiley & Sons NJ, USA. 141 154
34. I.A. Leneva, R.J. Russell, Y.S. Boriskin, and A.J. Hay Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of Arbidol Antivir. Res. 81 2 2009 132 140
35. Y.Y. Li, H.S. Wu, L. Tang, C.R. Feng, H.Y. Yu, Y.S. Yang, and B.J. Yang The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo Pharmacol. Res. 56 4 2007 335 343
36. A.H. Lipkus, Q. Yuan, K.A. Lucas, S.A. Funk, W.F. Bartelt, R.J. Schenck, and A.J. Trippe Structural diversity of organic chemistry. A scaffold analysis of the CAS registry J. Org. Chem. 73 12 2008 4443 4451
37. M.T. MacDonough, T.E. Strecker, E. Hamel, J.J. Hall, D.J. Chaplin, M.L. Trawick, and K.G. Pinney Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3′-hydroxy-4′- methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006) Bioorg. Med. Chem. 21 21 2013 6831 6843
38. D.J. Mack, M.L. Weinrich, E. Vitaku, and J.T. Njardarson Top 200 Brand Name Drugs by US Retail Sales in 2010. 2010 http://cbc.arizona.edu/njardarson/group/top-pharmaceuticals-poster
39. M. Medarde, A.C. Ramos, E. Caballero, R. Pelaez-Lamamie de Clairac, J.L. Lopez, D.G. Gravalos, and A.S. Feliciano Synthesis and pharmacological activity of diarylindole derivatives. Cytotoxic agents based on combretastatins Bioorg. Med. Chem. Lett. 9 16 1999 2303 2308
40. A. Meric Koksal, Y. Mine Yarim, I. Durmaz, and A. Rengul Cetin Design, synthesis, and biological evaluation of indole-based 1,4-disubstituted piperazines as cytotoxic agents Turk. J. Chem. 36 1 2012 515 525
41. S. Monica Estevao, C. Luisa Carvalho, D. Ribeiro, D. Couto, M. Freitas, A. Gomes, L.M. Ferreira, E. Fernandes, M. Manuel, and B. Marques Antioxidant activity of unexplored indole derivatives: synthesis and screening Eur. J. Med. Chem. 45 11 2010 4869 4878
42. G.D. Morse, R.C. Reichman, M.A. Fischl, M. Para, J. Leedom, W. Powderly, L.M. Demeter, L. Resnick, Y. Bassiakos, J. Timpone, S. Cox, and D. Batts Concentration-targeted phase I trials of Atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams Antivir. Res. 45 1 2000 47 58
43. M. Mosaad Sayed, Y. Mahmoud Moustafa, and A. Naglaa Mohamed Novel indolyl-pyrimidine derivatives: synthesis, antimicrobial and antioxidant evaluations Med. Chem. Res. 23 7 2014 3374 3388
44. K. Nagendra Kumar, K. Neha, A. Pankaj, N. Kumar, K. Chung Hyeok, V. Akhilesh Kumar, and C. Eun Ha Biomedical importance of indoles Molecules 18 6 2013 6620 6662
45. B. Narayana, B.V. Ashalatha, K.K. Vijaya Raj, J. Fernandes, and B.K. Sarojini Synthesis of some new biologically active 1,3,4-oxadiazolyl nitroindoles and a modified Fischer indole synthesis of ethyl nitro indole-2-carboxylates Bioorg. Med. Chem. 13 15 2005 4638 4644
46. S.M. Ostojic Yohimbine: the effects on body composition and exercise performance in soccer players Res. Sports Med. 14 4 2006 289 299
47. P. Rani, V.K. Srivastava, and A. Kumar Synthesis and anti-inflammatory activity of heterocyclic indole derivatives Eur. J. Med. Chem. 39 5 2004 449 452
48. H.M. Prince, and M. Bishton Panobinostat (LBH589): a novel pan-deacetylase inhibitor with activity in T cell lymphoma Hematology Meeting Reports 3 1 2009 33 38 (Parkville, Australia: Peter MacCallum Cancer Centre and University of Melbourne)
49. M.R.P. Queiroz, A.S. Abreu, M.S.D. Carvalho, P.M.T. Ferreira, N. Nazareth, and M.S. Nascimento Synthesis, (in vitro) antitumor and antimicrobial activity of some pyrazoline, pyridine and pyrimidine derivatives linked to indole moiety Bioorg. Med. Chem. 16 2 2008 5584 5596
50. M.A.A. Radwan, E.A. Ragab, N.M. Sabrya, and S.M. El-Shenawy Synthesis and biological evaluation of new 3-substituted indole derivatives as potential anti-inflammatory and analgesic agents Bioorg. Med. Chem. 15 11 2007 3832 3841
51. A.H. Rosengren, R. Jokubka, D. Tojjar, C. Granhall, O. Hansson, D.Q. Li, V. Nagaraj, T.M. Reinbothe, J. Tuncel, L. Eliasson, L. Groop, P. Rorsman, A. Salehi, V. Lyssenko, H. Luthman, and E. Renstrom Overexpression of Alpha2α-Adrenergic receptors contributes to type 2 diabetes Science 327 5962 2009 217 220
52. S. Samosorn, J.B. Bremner, A. Ball, and K. Lewis Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors Bioorg. Med. Chem. 14 3 2006 857 865
53. V. Sharma, K. Pradeep, and P. Devender Biological importance of the indole nucleus in recent years: a comprehensive review J. Heterocycl. Chem. 47 3 2010 491 502
54. G. Sivaprasad, P.T. Perumal, V.R. Prabavathy, and N. Mathivanan Synthesis and antimicrobial activity of pyrazolylbisindoles promising antifungal compounds Bioorg. Med. Chem. Lett. 16 No. 24 2006 6302 6305
55. P. Thirumurugan, S. Mahalaxmi, and P.T. Perumal Synthesis and anti-inflammatory activity of 3-indolyl pyridine derivatives through one-pot multi component reaction J. Chem. Sci. 122 6 2010 819 832
56. J. Ulrich, D. Nathalie, L. Amelie, B. Christian, L. Cedric, R. Jean-Michel, L. Olivier, M. Laurent, M. Jean-Yves, and R. Sylvain Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]-pyridine derivatives as CDK inhibitors and cytotoxic agents Bioorg. Med. Chem. 16 9 2008 4932 4953
57. M.G. Valverde, and T. Torroba Sulfur-nitrogen heterocycles Molecules 10 2005 318 320
58. 3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives Bioorg. Med. Chem. Lett. 20 17 2010 5054 5061
59. G. Waseem, and M.T. Hamann Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases Life Sci. 78 5 2005 442 453
60. J.A. Witjes, and P.S. Kolli Apaziquone for non-muscle invasive bladder cancer: a critical review Expert Opin. Investig. Drugs 17 7 2008 1085 1096
61. Y.S. Wu, M.S. Coumar, J.Y. Chang, H.Y. Sun, F.M. Kuo, C.C. Kuo, Y.J. Chen, C.Y. Chang, C.L. Hsiao, J.P. Liou, C.P. Chen, H.T. Yao, Y.K. Chiang, U.K. Tan, C.T. Chen, C.Y. Chu, S.Y. Wu, T.K. Yeh, C.Y. Lin, and H.P. Hsieh Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approach J. Med. Chem. 52 15 2009 4941 4945
62. G. Xu, V. Guo, C. Zhang, Q. He, B. Yang, and Y. Hu Synthesis and cytotoxicity of indolopyrrolemaleimides Chem. Pharm. Bull. 55 9 2007 1302 1307
63. H. Xu, and M. Lv Developments of indoles as anti-HIV-1 inhibitors Curr. Pharm. Des. 15 18 2009 2120 2148
64. X. Yu, E.J. Park, T.P. Kondratyuk, J.M. Pezzuto, and D. Sun Synthesis of 2-arylindole derivatives and evaluation as nitric oxide synthase and NFkB inhibitors Org. Biomol. Chem. 10 44 2012 8835 8847
65. F. Zhang, Y. Zhao, L. Sun, L. Ding, Y. Gu, and P. Gong Synthesis and antitumor activity of 2-amino-3-cyano-6-(1H-indol-3-yl)-4-phenylpyridine derivatives in vitro Eur. J. Med. Chem. 46 7 2011 3149 3157
66. Y. Zhang, P. Yang, C.J. Chou, C. Liu, X. Wang, and W. Xu Development of n-hydroxycinnamamide-based histone deacetylase inhibitors with an indole-containing cap group ACS Med. Chem. Lett. 4 2 2013 235 238